Dr. Egilman News
- Judge to Unseal Documents on the Eli Lilly Drug Zyprexa Saturday, September 6, 2008 @ 10:05PMA federal judge in Brooklyn decided to unseal confidential materials about Eli Lilly?s top-selling antipsychotic drug, citing questions about the way drugs are approved for new uses.
- Merck faces another round of criticism Tuesday, August 19, 2008 @ 4:29AMFor the third time in three years, a prominent medical journal has criticized Merck & Co. Inc. for misrepresenting research on its now-withdrawn pain reliever Vioxx.
- Merck faces another round of criticism Monday, August 18, 2008 @ 9:11PMFor the third time in three years, a prominent medical journal has criticized Merck & Co. for misrepresenting research on its now-withdrawn painkiller Vioxx.
- Agencies asked to ease safety rules Thursday, July 24, 2008 @ 1:14AMIn its final days in power, the Bush White House is rushing to have federal agencies water down the regulation of hazardous substances.
- Merck Responds To Journal Of The American Medical Association Articles Thursday, April 17, 2008 @ 3:13PMMerck & Co., Inc. today said it is committed tohigh standards of scientific integrity and ethics, and believes that many of the comments in aJournal of the American Medical Association (JAMA) news release and in the April 16 issue ofJAMA1 related to VIOXX are false, misleading or lack context. The Company said it was notgiven an opportunity to respond prior to publication.
- Merck Wrote Drug Studies for Doctors Wednesday, April 16, 2008 @ 11:41PM Documents unearthed in lawsuits over the pain drug Vioxx provide a rare, detailed look at the industry practice of ghostwriting medical research studies.
- Ghostwriters Used in Vioxx Studies, Article Says Tuesday, April 15, 2008 @ 10:40PM Merck drafted dozens of studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to an article in a leading medical journal.
- Merck Responds to Journal of the American Medical Association Articles Tuesday, April 15, 2008 @ 4:16PMMerck & Co., Inc. today said it is committed to high standards of scientific integrity and ethics, and believes that many of the comments in a Journal of the American Medical Association (JAMA) news release and in the April 16 issue of JAMA(1) related to VIOXX are false, misleading or lack context. The Company said it was not given an opportunity to respond prior to publication. The articles are ...
- Merck used ghostwriters and misrepresented data on Vioxx, article says Tuesday, April 15, 2008 @ 4:11PMThe article, based on documents unearthed in lawsuits over the pain drug Vioxx, provides a rare, detailed look in the industry practice of ghostwriting medical research studies that are then published in academic journals.
- Merck Responds to Journal of the American Medical Association Articles Tuesday, April 15, 2008 @ 3:54PM WHITEHOUSE STATION, N.J.----Merck & Co., Inc. today said it is committed to high standards of scientific integrity and ethics, and believes that many of the comments in a Journal of the American Medical Association news release and in the April 16 issue of JAMA1 related to VIOXX are false, misleading or lack context.
- â€15by2015†- A Campaign to Strengthen Primary Healthcare Around the World Monday, March 10, 2008 @ 12:27PM Tanzania, 2007. A male patient is admitted to a hospital with pneumonia and possibly HIV. Due to staffing problems and improper handling, the patient is not seen for a week. Upon finally being seen, he is found to be HIV negative.
- Drug company tries to suppress internal memos Thursday, January 24, 2008 @ 2:28PMThe drug maker Eli Lilly instigated legal action against a number of doctors, lawyers, journalists, and activists over hundreds of internal corporate documents and emails said to have been obtained by them regarding the antipsychotic drug olanzapine (Zyprexa).
- Jury sides with another defendant Saturday, December 22, 2007 @ 11:22AMTo the four jury trials that ended in defense verdicts last week, you can add a fifth: a case involving a worker who sought $6 million from his employer, NL Industries.
